Multipotential mesenchymal stem/progenitor cells (MSCs) can be induced to differentiate into bone, adipose, cartilage, muscle, and endothelium if these cells are cultured under specific permissive conditions [1, 2] . In rodents, a specific type of MSC (termed multipotent adult progenitor cell) can be isolated from bone marrow (BM) and contributes to most somatic cell types when injected into early blastocysts at the single-cell level [3] , kidney, lung, and liver). These cells are also present in the fetal environment (e.g., blood, liver, BM, and kidney). However, MSCs are a rare population in these tissues. Here we tried to identify cells with MSC-like potency in human placenta. We isolated adherent cells from trypsin-digested term placentas and established two clones by limiting dilution. We examined these cells for morphology, surface markers, gene expression patterns, and differentiation potential and found that they expressed several stem cell markers, hematopoietic/ endothelial cell-related genes, and organ-specific genes, as determined by reverse transcription-polymerase chain reaction and fluorescence-activated cell sorter analysis. They also showed osteogenic and adipogenic differentiation potentials under appropriate conditions. We suggest that placenta-derived cells have multilineage differentiation potential similar to MSCs in terms of morphology, cell-surface antigen expression, and gene expression patterns. The placenta may prove to be a useful source of MSCs.
blood [10] . A recent study showed that the population of MSC-like cells exists within the umbilical vein endothelial/ subendothelial layer [11] . Furthermore, MSCs are present in fetal organs, such as liver, BM, and kidney, and circulate in the blood of preterm fetuses [10, 12, 13] . However, fetal samples can be difficult to procure, and term cord blood compared with preterm is a poor source of MSCs [10] [11] [12] . Such being the case, searching for appropriate sources, avoiding ethical issues, and establishing suitable culture systems are a challenge.
In this study, we evaluated the possibility that MSCs or cells with MSC-like potency are present in the human term placenta, and we obtained evidence that cells with the phenotype of MSCs exist in this tissue.
Materials and Methods

Isolation and Culture of Placenta-Derived Cells
Term placentas (n = 57; clinically normal pregnancies, caesarean section) were collected after obtaining written informed consent from donors to the Tokyo Cord Blood Bank.
The internal area (approximately 1 cm 3 ) of central placenta lobules was minced, hemolyzed, trypsinized (37°C for 5 minutes), and finally prepared in both single-cell suspensions and small digested residues. These samples were cultured with α-minimum essential medium (MEM; SigmaAldrich Co., St. Louis, http://www.sigmaaldrich.com) and supplemented with 15% fetal bovine serum (FBS; HyClone Laboratories, Logan, UT, http://www.hyclone.com), 100 U/ml penicillin, and 100 µg/ml streptomycin (Invitrogen, Paisley, U.K., http://www.invitrogen.com). Cultures were maintained at 37°C in a humidified atmosphere with 5% CO 2 . Three to 5 days after initiating incubation, the small digested residues were removed and the culture was continued. Approximately 3 to 4 weeks later, there were some colonies that contained 50 or more fibroblast-like cells that were more than 50% confluent; they were then trypsinized using 0.05% trypsin (Invitrogen) and replated at a 1:4 dilution. Under the same conditions, placenta-derived cells were continued to culture.
Fluorescence In Situ Hybridization Analysis
Human X/Y chromosomes of placenta-derived cells (male, n = 3; female, n = 3; passages two and three) were cultured on silica-coating slides and examined using CEP X/Y DNA probe kits (Vysis, Inc., Downers Grove, IL, http://www. vysis.com) according to the manufacturer's instructions. The slides were scanned under a fluorescence microscope using a rhodamine/fluorescein isothiocyanate (FITC) filter for X/Y chromosomes and a UV filter for 4',6-diamidine-2'-phenylindole dihydrochloride-stained cell nuclei.
Fluorescence-Activated Cell Sorter Analysis
Frozen and thawed placenta-derived cells (n = 3, passages 9-12) were trypsinized and incubated with medium containing 15% FBS-2 mM EDTA (pH 8.0) for 3 hours. [20] ; renin and albumin [21] ; GFAP [22] ; and amylase and insulin [23] .
Differentiation Studies
Passage 2 through 11 placenta-derived cells, including frozen and thawed samples (n = 8), were cultured either in an osteogenic (0.1 µM dexamethasone, 10 mM β-glycerol phosphate, 50 µM ascorbate) or adipogenic (1 µM dexamethasone, 5 µg/ml insulin, 0.5 mM isobutylmethylxanthine, 60 µM indomethacin) medium (all chemicals from Sigma) [10] on two-well Permanox slides (Nalge Nunc International, Naperville, IL). After 2 weeks, osteogenic differentiation was evaluated after 1% Alizarin Red S (Sigma) staining, and adipogenic differentiation was assessed using Oil Red O (Sigma) staining [2] .
Subcloning and Characterization of Placenta-Derived Clones
The . After subcloning, we selected single retroviral-inserted subclones by Southern blot analysis using a GFP cDNA probe. Two clones were obtained, and then we carried out a FACS and RT-PCR analysis and differentiation studies for characterization of these clones.
Results
Characterization of Placenta-Derived Cells
Searching for alternative sources of MSCs, we attempted to prepare human term placentas and isolated fibroblast-like cells from every placenta isolation (n = 57; Fig. 1 ). In a single-cell suspension culture of the isolated placenta, cells firstly formed colony-forming unit fibroblast (CFU-F)-like colonies (Figs. 1A, b) . On the other hand, in the culture of small trypsin-digested residues of placenta, cells began to migrate and proliferate (data not shown). After the first passage, cells from both samples expanded in the same monolayer manner (Fig. 1A, a-c) . Cord blood (CB) is a rich source of hematopoietic stem cells and MSCs, and the term placenta contains much CB, primarily adherent cells derived from freshly isolated CB mononuclear cells (n = 77). However, CBs were obtained (after receiving the informed consent from Kiyosenomori Hospital, Tokyo) but did not survive in α-MEM containing 15% FBS. To determine whether these cells were from maternal or fetal parts of the placenta, we did a fluorescence in situ hybridization analysis using Xand Y-probes. These cells were positive for X-and Y-signals, indicating that they were from a fetal part of the placenta (Fig. 1B) . The placenta-derived cells were classified into two groups according to growth characteristics; one could proliferate more than 20 passages (Fig. 1C , Nos. 40 and 29), and the other went into replicative senescence between 10 and 20 passages (Fig. 1C , Nos. 41 and 44). The former type had a small and homogeneous morphology, but the latter type was of a bigger shape than the former. We also examined the surface marker profile of the above three representative placenta-derived cell lines using FACS, and these three lines had a similar phenotype, as follows: CD45 
Gene Expression Patterns of Placenta-Derived Cells
For a closer study of placenta-derived cells, we did a RT-PCR analysis for various genes, including stem cell markers, hematopoietic/endothelial cell-related genes, and organspecific genes. The placenta-derived cells expressed many of the genes derived from mesoderm, ectoderm, and endoderm (Fig. 2) . Additionally, expression patterns of stem cell markers and hematopoietic/endothelial cell-related genes in placenta-derived cells were similar to those of human BM (hBM)-derived MSCs (Fig. 2, lane 2) .
Differentiation Potential of Placenta-Derived Cells
To estimate the potential to differentiate into osteoblasts and adipocytes, the placenta-derived cells were cultured in osteogenic or adipogenic medium. At the end of the induction periods, most of the cells were Alizarin Red S-positive (Figs. 3B, 3C ) or Oil Red O-positive (Figs. 3E, 3F ), indicating differentiation to osteoblasts or adipocytes, respectively. In contrast, cells cultured with regular medium were not significantly stained (Figs. 3A, 3D ). Such data indicate that the placenta-derived cells had bidirectional differentiation potency.
Subcloning of Placenta-Derived Cells
The placenta-derived cells used in the above experiments are obviously heterogeneous and may be a mixture of progenitors that can differentiate into specific lineages. To Fukuchi, Nakajima, Sugiyama et al. Immunophenotype of placenta-derived cells. Cells were stained with phycoerythrin-conjugated or fluorescein isothiocyanate-conjugated antibodies against CD45, CD31, AC133, CD54, CD29, CD44, or immunoglobulin isotype control antibodies. Cells were analyzed using fluorescence-activated cell sorter Calibur. Individual placenta-derived cells were given serial numbers of placenta isolation. Representative samples were used for these figures. (Figure 1 D continued on next page.) exclude this possibility, we attempted to subclone No. 40 placenta-derived cells showing the human MSC (hMSC)-like gene expression pattern using RT-PCR (Fig. 2, lanes 2  and 7) . We established two clones, B2 and F4 (Fig. 4A, lanes  1 and 9) Figs. 1-3) . Moreover, these phenotypes were similar to those of other placenta-derived cell lines. Such data suggest that although the placenta-derived cells are considered to be polyclonal, most of the clones are similar in gene-expression profiles and retain the differentiation capacity to osteoblasts and adipocytes.
Discussion
In this study, we successfully isolated placenta-derived cells from human term placentas (n = 57) and then characterized morphology, cell-surface antigens, gene expression patterns, and differentiation capacity of these cells. Results of RT-PCR analysis of 15 individual placenta-derived cells showed that the expression patterns of seven genes (HOXB4, CD34, AC133, flk-1, Tie-2, GATA-4, and myogenin) varied but expressions of 14 other genes were quite similar (Fig. 2 Fukuchi, Nakajima, Sugiyama et al. shows evidence of six placenta-derived cells; nine are not shown). These expression patterns resemble those of hBMderived MSCs, except for renin and flt-1 (Fig. 2, lane 2) . showed that the expressions of HOXB4, CD34, Tie-2, and GATA-4 were different among these groups. The former more resembled the hBM-derived MSCs for gene expression patterns (Fig. 2) . Collectively, these results indicate that the placenta-derived cells have MSC-like gene expression patterns. In addition, they showed a differentiation capacity toward both osteoblasts and adipocytes (Fig. 3) , suggesting that these cells have MSC-like differentiation potential. Because the original culture of 57 placenta-derived cell lines should be a mixture of a variety of cell types, we attempted to subclone these cells to do a detailed analysis. HOXB4 , and β2-microglobulin were used for EoL-3. GATA-2, CBFβ, TAL-1, CD34,AC133, flk-1, and flt-1 were used for TF-1. NKx2.5 and GATA-4 were used for human heart RNA. Renin and myogenin were used for human kidney RNA and skeletal muscle RNA, respectively. Nestin and GFAP were used for human brain RNA. α-1-fetoprotein and albumin were used for human liver RNA. Amylase and insulin were used for human pancreas RNA). In this figure, we took up the data from the five representative placenta-derived cells, and each of placenta-derived cells was shown by serial numbers of placenta isolation.
Two established clones retained almost all of the phenotypes of parental No. 40 placenta-derived cells, including morphology, cell-surface populations, gene expression patterns, and differentiation capacity. However, these clones also had some differences in mRNA expression, such as CD34 and α-1-fetoprotein. These genes were upregulated compared with the parent mixture cells (Figs. 2, 4C) . In some reports, small proportions of hMSCs expressed low levels of CD34 [6, 25] . Further experiments are required to determine the meaning of expressions of these genes.
Rex-1 is known to be important for maintaining undifferentiated embryonic stem cells [26, 27] . However, the role of this gene in MSCs is not clear. The result of RT-PCR analysis showed that Rex-1 is expressed in both BM-derived MSCs and placenta-derived cells (Fig. 2) but not in the two clones (Fig. 4C) . Analysis of parental placenta-derived cells at various time points during passages (passages 3, 5, 9, and 18 for original cells; passages 13 and 26 for GFP-labeled mixture cells) using RT-PCR showed that only Rex-1 expression switched from positive (before passage 5, Fig. 2 ) to negative (after passage 9; data not shown). Additional analysis is required to know the role of Rex-1 in placentaderived cells.
Interestingly, cell-surface markers analyzed using FACS revealed that the placenta-derived mixture cells and clones had the CD45 low CD31 -AC133 -CD54 + CD29 + CD44 + phenotype (Figs. 1D, 4B) , and the expression of CD45 and AC133 antigens differed from MSCs derived from other sources [2, 7, 10, 24] . As for the expression of AC133, the results were negative with FACS yet positive with RT-PCR analysis. This contradictory finding may be due to a damaged AC133 epitope by trypsin treatment of the cells. As for the expression of CD45, some reports showed that unprocessed or fresh MSCs were CD45 med,low , whereas cultured MSCs and more mature cells were CD45 - [24, 28] . However, as our results showed, the expression of CD45 was low during passages. The CD45 low phenotype might be one of the specific characteristics of the placenta-derived cells. This study showed that the placenta-derived MSClike cells could be easily isolated and expanded without morphological and characteristic changes in medium supplemented only with FBS. Therefore, the placenta may prove to be an attractive and rich source of MSCs. Further studies are required to better understand the precise nature of placenta-derived cells and to explore their potential clinical applications. a, d, g, j) for 2 weeks. After the culture periods, each of the clones was evaluated for osteogenic or adipogenic differentiation using specific staining and hematoxylin counterstaining. Magnification: a, b, d, e, g, h, j, k, ✕ 40; c, f, i, l, ✕ 100.
